Abstract
Background
This study aimed to evaluate the prognostic impact of pT2 subclassification according to the depth of muscularis propria (MP) invasion and to explore the clinicopathologic factors correlated with lymph node metastasis (LNM) and postoperative hematogenous metastasis in pT2 colorectal cancer.
Methods
A total of 317 patients with pT2 colorectal cancer were reviewed. pT2a represents the infiltration of the inner circumferential layer of the MP, and pT2b represents the infiltration of the outer longitudinal layer of the MP. Clinicopathologic factors and overall survival rates were compared in patients with pT2a and pT2b stage cancers. Multivariate analysis was performed to identify the significantly important prognostic factors. Univariate and multivariate analyses were performed, respectively, to identify the significantly important clinicopathologic factors correlated with LNM and postoperative hematogenous metastasis in pT2 colorectal cancer.
Results
According to the depth of MP invasion, 107 patients were classified as pT2a and 210 patients were classified as pT2b. Among them, there were 55 patients with LNM, 34 patients with postoperative hematogenous metastasis. There was significant difference in most of clinicopathologic features between patients in the pT2a and pT2b stages. Multivariate analysis identified pN stage (P < .001) and tumor location (P = .036) were independent factors affecting the prognosis. However, no apparent difference was observed between pT2a versus pT2b cancer. Univariate and multivariate analyses uniformly identified lymphovascular invasion (P = .035) and the depth of MP invasion (P = .005) as significantly correlated with LNM. Multivariate analysis found tumor location (P = .021) and the presence or absence of LNM (P < .001) were important factors affecting postoperative hematogenous metastasis.
Conclusions
In pT2 colorectal cancer treated with R0 surgery, there is a high risk of LNM in deep MP invasion versus superficial MP invasion. The pT2 subclassification system had no significant advantage in identifying a different prognosis, except for predicting the LNM before surgery. Rectal cancer and the presence of LNM were high-risk factors resulting in hematogenous metastasis postoperatively.
Similar content being viewed by others
References
Schottenfeld D, Winawer SJ. Cancers of the large intestine. In: Schottenfeld D, Fraumeni JF, eitors. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press; 1996.
Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8–31.
Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411:390–5.
Tsukuma H, Ajiki W. Descriptive epidemiology of colorectal cancer—international comparison. Nippon Rinsho. 2003;61(Suppl 7):25–30.
Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening for colorectal cancer: CT colonography immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin. 2003;53:44–55.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer Statistics, 2008. CA Cancer J Clin. 2008;58:71–96.
Xu AG, Jiang B, Zhong XH, Liu JH. Clinical epidemiological characteristics of 3870 cases of colorectal cancers in Guangdong region. Zhonghua Nei Ke Za Zhi. 2006;45:9–12.
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Kitamura K, Nishida S, Yamamoto K, Ichikawa D, Okamoto K, Sawai K, et al. Mp colorectal cancer should be defined as early colorectal cancer. Tohoku J Exp Med. 1998;184:285–93.
Chok KS, Law WL. Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg. 2007;31:1485–90.
Losi L, Ponti G, Gregorio CD, Marino M, Rossi G, Pedroni M, et al. Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma. Pathol Res Pract. 2006;202:663–70.
Pollheimer MJ, Kornprat P, Pollheimer VS, Lindtner RA, Schlemmer A, Rehak P, et al. Clinical significance of pT sub-classification in surgical pathology of colorectal cancer. Int J Colorectal Dis. 2010;25:187–96.
Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss Inc.; 1997.
Boudreaux KJ Jr, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, et al. Comparison of American Joint Committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer. J Urol. 2009;181:540–5; discussion 546.
Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. J Urol. 2006;176:493–8; discussion 498–9.
Sun Z, Zhu GL, Lu C, Guo PT, Huang BJ, Li K et al. A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa. Ann Surg. 2009;249:768–75.
Ricciardi R, Madoff RD, Rothenberger DA, Baxter NN. Population-based analyses of lymph node metastases in colorectal cancer. Clin Gastroenterol Hepatol. 2006;4:1522–7.
Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK, et al. Metastatic potential in T1 and T2 colorectal cancer. Hepatogastroenterology. 2005;52:1688–91.
Masaki T, Matsuoka H, Sugiyama M, Abe N, Sakamoto A, Watanabe T, et al. Tumor budding and evidence-based treatment of T2 rectal carcinomas. J Surg Oncol. 2005;92:59–63.
Sitzler PJ, Seow-Choen F, Ho YH, Leong AP. Lymph node involvement and tumor depth in rectal cancers: an analysis of 805 patients. Dis Colon Rectum. 1997;40:1472–6.
Sohn DK, Chang HJ, Park JW, Choi DH, Han KS, Hong CW, et al. Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type. J Clin Pathol. 2007;60:912–5.
Yamamoto S, Watanabe M, Hasegawa H, Baba H, Yoshinare K, Shiraishi J, et al. The risk of lymph node metastasis in T1 colorectal carcinoma. Hepatogastroenterology. 2004;51:998–1000.
Tominaga K, Nakanishi Y, Nimura S, Yoshimura K, Sakai Y, Shimoda T. Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis Colon Rectum. 2005;48:92–100.
Acknowledgment
This work was supported by National Science Foundation of China (No. 30772137 and No. 30972879) and Specialized Research Fund for the Doctoral Program of Higher Education (No. 200801590006) and the Key Laboratory Programme of Education Department of Liaoning Province (No. 2008S229).
Author information
Authors and Affiliations
Corresponding author
Additional information
Lin-lin Tong and Peng Gao contributed equally to this work.
Rights and permissions
About this article
Cite this article
Tong, Ll., Gao, P., Wang, Zn. et al. Is pT2 Subclassification Feasible to Predict Patient Outcome in Colorectal Cancer?. Ann Surg Oncol 18, 1389–1396 (2011). https://doi.org/10.1245/s10434-010-1440-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-010-1440-2